CytomX Therapeutics CTMX Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CytomX Therapeutics's change in AR?
- CytomX Therapeutics (CTMX) reported change in AR of -$1.37M in Q1 2026.
- How has CytomX Therapeutics's change in AR changed year-over-year?
- CytomX Therapeutics's change in AR decreased by 19.2% year-over-year, from -$1.15M to -$1.37M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.